NON-ALCOHOLIC STEATOHEPATITIS

This study is testing if a medication called semaglutide, currently used for diabetes, can help people with non-alcoholic fatty liver disease (NAFLD). Researchers want to see if the drug can reduce liver fat and inflammation. They are also studying how the liver reacts to sugar t…

This study is testing whether a minimally invasive endoscopic procedure to reduce stomach size, combined with lifestyle changes, is better than lifestyle changes alone for treating a serious fatty liver disease called MASH in people with obesity. Researchers will compare the two …

This study aims to find better, non-invasive ways to diagnose liver scarring (fibrosis) in people with fatty liver disease. Researchers will collect blood samples from 575 participants and compare new blood tests and AI-powered ultrasound to the current gold standard, a liver bio…

This study aims to find liver scarring earlier by combining multiple tests into one smarter system. Researchers will analyze blood, genetics, and gut bacteria from 1,200 people at risk for liver disease. The goal is to create a better tool that catches problems sooner, so fewer p…

This study is testing a new, quick ultrasound method to check for liver scarring (fibrosis) in overweight patients with fatty liver disease (NAFLD/NASH). Researchers want to see if this method, done during a routine stomach scope, is more accurate than other non-invasive tests fo…

This study aims to collect blood and tissue samples from 800 patients with various chronic liver diseases and liver cancer. Researchers will use these samples to create better laboratory models, like mini-tumors in dishes and mice, to study how these diseases progress and to test…

This study aims to find out how many adults in Olmsted County, Minnesota, have a common liver condition called NAFLD (fatty liver disease) and its more serious form, NASH. Researchers will enroll 800 local residents to gather detailed health information and track their long-term …